🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the curr...
Status
Completed
Location
Helsinki University Hospital
Start Date
2021-11-11
Trial ID
NCT05084222
A randomized clinical study to assess the impact of Symbicort® pMDI medicat...
Status
Completed
Location
Research Site
Start Date
2016-08-12
Trial ID
NCT02864342
Treatments Being Tested
This is a variable length study to evaluate the efficacy and safety of bude...
Status
Completed
Location
Research Site
Start Date
2021-03-01
Trial ID
NCT04609904
Treatments Being Tested
The purpose of this study is to investigate the effect of combined treatmen...
Status
Completed
Location
Research Site
Start Date
2007-05
Trial ID
NCT00496470
Treatments Being Tested
The purpose of the this study is to evaluate the efficacy and safety of 2 a...
Status
Completed
Location
Research Site
Start Date
2007-09
Trial ID
NCT00536731
Treatments Being Tested
This is a randomized, multi-center, active-controlled, repeated measures de...
Status
Completed
Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Start Date
2016-04
Trial ID
NCT02757209
A Randomized, Double-Blind, Parallel Group, 28-Week Chronic Dosing, Multi-C...
Status
Completed
Location
Research Site
Start Date
2016-08-09
Trial ID
NCT03262012
Treatments Being Tested
1. The primary objective of this study is: * To evaluate the magnitude ...
Status
Completed
Location
Research Site
Start Date
2009-09
Trial ID
NCT00989833
Treatments Being Tested
This study is conducted to assess whether training participants on proper u...
Status
Completed
Location
Teva Investigational Site 34092
Start Date
2014-05-28
Trial ID
NCT02062463